ESC 365 - Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis

HFA Premium Access

Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis

Session: Poster Session 2 - Atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Professor G. Savarese (Stockholm, SE)

Event: HEART FAILURE 2016

Congress Presentation

About the speaker

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)

64 presentations

13 followers

9 more presentations in this session

Characteristics of heart failure decompensation on atrial fibrillation and on sinus rhythm.

Speaker: Professor N. Koziolova (Perm, RU)

Central blood pressure at different pulse wave velocity and atrial fibrillation recurrence in heart failure patients with preserved ejection fraction

Speaker: Associate Professor A. Shavarov (Moscow, RU)

Optimization of warfarin dosing for patients with chronic kidney disease

Speaker: Doctor Z. Salpagarova (Moscow, RU)

Do patients under non-vitamin K oral anticoagulants need to switch to parenteral anticoagulation when admitted for acute decompensated heart failure?

Speaker: Doctor J. Bicho Augusto (London, GB)

Risk of recurrent atrial fibrillation after pulmanary vein isolation- a gender sprecific approach.

Speaker: Doctor E. Wellnhofer (Berlin, DE)

Access the full session

Poster Session 2 - Atrial fibrillation

Speakers: Professor G. Savarese, Professor N. Koziolova, Associate Professor A. Shavarov, Doctor Z. Salpagarova, Doctor J. Bicho Augusto...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources